Patents Assigned to Avita Medical Ltd.
-
Patent number: 11124752Abstract: The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or openings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.Type: GrantFiled: February 11, 2020Date of Patent: September 21, 2021Assignee: AVITA MEDICAL LTDInventors: Andrew Perry Quick, David Allen Fencil, William Ford Dolphin
-
Patent number: 10729536Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.Type: GrantFiled: December 12, 2017Date of Patent: August 4, 2020Assignee: AVITA MEDICAL LTDInventors: Fiona M. Wood, Marie L. Stoner
-
Patent number: 10631974Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.Type: GrantFiled: June 10, 2019Date of Patent: April 28, 2020Assignee: AVITA MEDICAL LTDInventors: Fiona M. Wood, Marie L. Stoner
-
Patent number: 10626358Abstract: The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or openings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.Type: GrantFiled: March 14, 2014Date of Patent: April 21, 2020Assignee: AVITA MEDICAL LTDInventors: Andrew Perry Quick, David Allen Fencil, William Ford Dolphin
-
Patent number: 9867692Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for grafting to a patient. In applying the method and/or in using the device, donor tissue is harvested, subjected to a cell dissociation treatment, cells suitable for grafting back to a patient are collected and dispersed in a solution that is suitable for immediate dispersion over the recipient graft site.Type: GrantFiled: March 12, 2015Date of Patent: January 16, 2018Assignee: Avita Medical Ltd.Inventors: Fiona M. Wood, Marie L. Stoner
-
Publication number: 20160024450Abstract: The present invention provides for methods and at least partially automated devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. Tissue regeneration in humans is extremely limited and constitutes a major challenge to the repair of damaged organ function. Wound treatment is a typical area where tissue regeneration is required. Wounds (lacerations or openings) in mammalian tissue can result in tissue disruption and coagulation of the microvasculature at the wound face.Type: ApplicationFiled: March 14, 2014Publication date: January 28, 2016Applicant: AVITA MEDICAL LTD.Inventors: Andrew Perry Quick, David Allen Fencil, William Ford Dolphin
-
Publication number: 20150079153Abstract: The present invention provides for methods and devices suitable for producing a transplantable cellular suspension of living tissue suitable for promoting tissue regeneration in an epithelium-related procedure, as well as compositions produced therefrom. The cellular suspension can include viable and functioning cells at various stages of differentiation, including undifferentiated/progenitor cells and differentiated cells, as well as those in between. In certain embodiments, the cellular suspension can be subjected to a stress to induce a heat shock response therein, or be exposed to an exogenously supplied agent such as heat shock protein or a fragment thereof, hyaluronic acid, platelet-enriched plasma, and/or growth factors. The cellular suspension can be applied directly to a patient's recipient site for in vivo regeneration, or be cultured or seeded to a matrix for in vitro growth/regeneration.Type: ApplicationFiled: March 14, 2013Publication date: March 19, 2015Applicant: Avita Medical Ltd.Inventors: Andrew Quick, William Dolphin